Endophthalmitis is not a "never event"

Ophthalmology

Volumn 119, Issue 8, 2012, Pages 1507-1508

  Schachat, Andrew P ^a   Rosenfeld, Philip J ^a   Liesegang, Thomas J ^a   Stewart, Michael W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BEVACIZUMAB; POVIDONE IODINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VASCULOTROPIN INHIBITOR;

ANESTHESIA; ANTIBIOTIC THERAPY; BACTERIAL COUNT; COUGHING; DRUG EXPOSURE; EDITORIAL; ENDOPHTHALMITIS; HEART INFARCTION; HUMAN; HYPERTENSION; INFECTION RATE; MOUTH FLORA; MYDRIASIS; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PARACENTESIS; PRIORITY JOURNAL; RETINA DETACHMENT; RISK REDUCTION; STAPHYLOCOCCUS INFECTION; STROKE; TRAUMATIC CATARACT;

ANGIOGENESIS INHIBITORS; ANTI-BACTERIAL AGENTS; BACTERIA; CONJUNCTIVA; DRUG RESISTANCE, BACTERIAL; ENDOPHTHALMITIS; EYE INFECTIONS, BACTERIAL; HUMANS; INTRAVITREAL INJECTIONS; NASOPHARYNX; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84864472113     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2012.03.048     Document Type: Editorial

References (14)

1. S. Day, K. Acquah, P. Mruthyunjaya Ocular complications after anti-vascular endothelial growth factor therapy in Medicare patients with age-related macular degeneration Am J Ophthalmol 152 2011 266 272
2. A.A. Moshfeghi, P.J. Rosenfeld, H.W. Flynn Endophthalmitis after intravitreal anti-vascular endothelial growth factor antagonists; a six-year experience at a university referral center Retina 31 2011 662 668
3. C.A. McCannel Meta-analysis of endophthalmitis following intravitreal injection of anti-VEGF agents: causative organisms and possible prevention strategies Retina 31 2011 654 661
4. M.W. Stewart Endophthalmitis after injections of anti-vascular endothelial growth factor drugs Retina 311 2011 981 982
5. L.H. Curtis, M.S. Hammill, K.A. Schulman Risks of mortality, myocardial infarction, bleeding and stroke associated with therapies for age-related macular degeneration Arch Ophthalmol 128 2010 1273 1279
6. B.A. Frost, M.A. Kainer Safe preparation and administration of intravitreal bevacizumab injections N Engl J Med 365 2011 2238
7. L.P. Aiello, A.J. Brucker, S. Chang Evolving guidelines for intravitreous injections Retina 24 2004 S3 S19
8. S.J. Kim, H.S. Toma, N.K. Midha Antibiotic resistance of conjunctiva and nasopharynx evaluation study: a prospective study of patients undergoing intravitreal injections Ophthalmology 117 2010 2372 2378
9. S.J. Kim, H.S. Toma Ophthalmic antibiotics and antimicrobial resistance Ophthalmology 118 2011 1358 1363
10. S.B. Dave, H.S. Toma, S.J. Kim Ophthalmic antibiotic use and multidrug-resistant staphylococcus epidermidis Ophthalmology 118 2011 2035 2040
11. E. Milder, J. Vander, C. Shah Changes in antibiotic resistance patterns of conjunctival flora due to repeated use of topical antibiotics after intravitreal injection Ophthalmology 119 2012 1420 1424
12. C.C. Wyckoff, H.W. Flynn Endophthalmitis after intravitreal injection: prevention and management Retina 31 2011 633 635
13. C.S.Y. Cheung, A.W.T. Wong, A. Lui Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections Ophthalmology 119 2012 1609 1614
14. F. Lum, A.P. Schachat The quest to eliminate "never events." Ophthalmology 116 2009 1021 1022